Special Issue "A Prescription to Optimize Cancer Care: The Expanding Role of the Oncology Pharmacist "
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (31 May 2020).
School of Pharmacy, University of Connecticut, 69 North Eagleville Road, U-3092, Storrs, Connecticut 06269-3092
Interests: adherence and appropriate education of oral anticancer agents; role of the oncology pharmacist; oncology supportive care
Interests: oral anticancer agents; patient education; symptom management
Interests: patient education; thoracic cancers; symptom management; patient reported outcomes
Oncology pharmacy is an evolving specialty area of pharmacy practice. Pharmacists in this a specialty area ensure the safety and appropriateness of anticancer therapy for patients through their training and expertise in oncology diseases and management. Oncology pharmacists have become embedded in many healthcare teams, providing direct patient care or participating in clinical decision making. Oncology pharmacists may also operate in sterile compounding, specialty pharmacy, clinical research, or adminstrative roles.
On behalf of Pharmacy, we invite you to share your experiences in the field of oncology pharmacy to advance our field of practice. We hope this Special Issue will inspire others to futher develop their clinical practice, implement new services, and continue to advocate on behalf of the oncology patients we serve.
Assoc. Prof. Lisa Holle
Dr. Kate D. Jeffers
Dr. Eve Segal
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Oncology pharmacist
- Hematology pharmacist
- Infusion pharmacy
- Oral anticancer therapy
- Patient education